Inadequate Manufacturing Capabilities Posing Challenge to Biosimilars Market
As biosimilars are developed from living organisms, so they are more complex in nature. They require a manufacturing process that can help in the development of products which are comparable to reference products. Since the manufacturing processes are not revealed by the innovators publicly, biosimilar developers need to discover adequate process conditions that ensure comparability to the reference products.
View full press release